Рубрика
Blog
-
2023
-
EC grants approval for AbbVie’s Skyrizi to treat Crohn’s disease
-
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B
-
New CRISPR-based tool inserts large DNA sequences at desired sites in cells
-
Biovac and IVI enter deal to develop oral cholera vaccine
-
Diagnostic marker found for deadly brain disease marked by dementia, movement problems.
-
FDA Accepts New Data on Apellis’ New Drug Application
-
FDA Approves New Dosing Schedule for Jazz Pharmaceuticals’ Rylaze
-
J&J builds case for antidepressant Spravato with head-to-head trial
-
Merck bulks up in haematology, buying Imago
-
FDA Grants Breakthrough Therapy Status to Iveric Bio’s Zimura for AMD